Quarterly report [Sections 13 or 15(d)]

Segment Information (Tables)

v3.26.3
Segment Information (Tables)
 9 Months Ended
Sep. 30, 2026
Segment Reporting [Abstract]  
Schedule of Reportable Business Segment Information
Reportable business segment information for the three and nine months ended September 30, 2026 and 2025, is as follows (dollar amounts in thousands):
Three Months Ended September 30, 2026 Asia Europe North America Latin America and Other Total
Net sales $ 55,056  $ 22,076  $ 34,009  $ 5,462  $ 116,603 
Cost of sales 12,678  5,754  11,258  1,951 
Volume incentives 19,624  9,016  7,065  1,660 
Selling, general and administrative (1) 13,307  4,955  10,434  1,319 
Segment operating income $ 9,447  $ 2,351  $ 5,252  $ 532  $ 17,582 
Unallocated corporate selling, general and administrative expense (12,300)
Operating income 5,282 
Interest and other income, net 101 
Interest expense (30)
Foreign exchange gains, net 15 
Income from operations before provision for income taxes $ 5,368 

Three Months Ended September 30, 2025 Asia Europe North America Latin America and Other Total
Net sales $ 64,725  $ 22,107  $ 36,224  $ 5,283  $ 128,339 
Cost of sales 13,906  6,464  12,043  1,877 
Volume incentives 21,524  8,726  7,383  1,715 
Selling, general and administrative (1) 16,177  4,599  9,009  1,416 
Segment operating income $ 13,118  $ 2,318  $ 7,789  $ 275  $ 23,500 
Unallocated corporate selling, general and administrative expense (14,525)
Operating income 8,975 
Interest and other income, net 51 
Interest expense (26)
Foreign exchange gains, net 672 
Income from operations before provision for income taxes $ 9,672 
Nine Months Ended September 30, 2026 Asia Europe North America Latin America and Other Total
Net sales $ 160,236  $ 71,165  $ 108,283  $ 16,796  $ 356,480 
Cost of sales 35,481  19,414  34,599  5,873 
Volume incentives 54,089  28,856  22,051  5,079 
Selling, general and administrative (1) 42,395  15,678  29,345  4,186 
Segment operating income $ 28,271  $ 7,217  $ 22,288  $ 1,658  $ 59,434 
Unallocated corporate selling, general and administrative expense (39,126)
Operating income 20,308 
Interest and other income, net 336 
Interest expense (118)
Foreign exchange losses, net (1,637)
Income from operations before provision for income taxes $ 18,889 

Nine Months Ended September 30, 2025 Asia Europe North America Latin America and Other Total
Net sales $ 166,042  $ 67,962  $ 106,219  $ 16,114  $ 356,337 
Cost of sales 36,538  20,000  35,817  6,037 
Volume incentives 54,666  27,238  21,853  4,795 
Selling, general and administrative (1) 43,085  14,498  26,627  4,259 
Segment operating income $ 31,753  $ 6,226  $ 21,922  $ 1,023  $ 60,924 
Unallocated corporate selling, general and administrative expense (41,503)
Operating income 19,421 
Interest and other income, net 524 
Interest expense (71)
Foreign exchange gains, net 4,451 
Income from operations before provision for income taxes $ 24,325 
_________________________________________

(1)    Service fees in China totaled $2.2 million and $9.6 million for the three- and nine-month periods ended September 30, 2026, respectively, compared to $4.6 million and $10.9 million for the three- and nine-month periods ended September 30, 2025. These service fees are included in selling, general and administrative expenses.
Depreciation and amortization by reportable business segment for the three and nine months ended September 30, 2026 and 2025, are as follows (dollar amounts in thousands):
Three Months Ended
September 30,		 Nine Months Ended
September 30,
2026 2025 2026 2025
Depreciation and amortization:
Asia $ 494  $ 466  $ 1,331  $ 1,445 
Europe 9  25  38  81 
North America 2,697  3,036  8,333  8,977 
Latin America and Other 11  12  33  35 
Total depreciation and amortization $ 3,211  $ 3,539  $ 9,735  $ 10,538 
Schedule of Consolidated Net Sales Revenue by Geographical Locations
The table below reflects sales based upon the sales location where they occurred. From an individual country/region perspective, the United States, Japan, Taiwan and South Korea comprise 10 percent or more of consolidated net sales for the three- and nine-month periods ended September 30, 2026 and 2025, as follows (dollar amounts in thousands):  
Three Months Ended
September 30,		 Nine Months Ended
September 30,
2026 2025 2026 2025
Net sales:
United States $ 31,713  $ 33,721  $ 100,920  $ 98,687 
Japan 17,270  17,704  47,940  41,911 
Taiwan 16,062  18,854  44,778  53,446 
South Korea 14,474  15,199  38,725  38,516 
Other 37,084  42,861  124,117  123,777 
Total net sales $ 116,603  $ 128,339  $ 356,480  $ 356,337 
Schedule of Net Sales Generated By Product Line
Net sales generated by each product line for the three and nine months ended September 30, 2026 and 2025, are as follows (dollar amounts in thousands):

Three Months Ended September 30, 2026 Asia Europe North America Latin America and Other Total
General health $ 21,427 $ 9,806 $ 15,056 $ 1,608 $ 47,897
Immune 4,239 1,844 3,024 412 9,519
Cardiovascular 13,086 2,727 3,675 408 19,896
Digestive 7,490 5,821 9,673 2,664 25,648
Personal care 5,907 1,238 1,854 197 9,196
Weight management 2,907 640 727 173 4,447
Total net sales by segment $ 55,056 $ 22,076 $ 34,009 $ 5,462 $ 116,603

Three Months Ended September 30, 2025 Asia Europe North America Latin America and Other Total
General health $ 24,817 $ 9,267 $ 16,231 $ 1,571 $ 51,886
Immune 4,456 2,046 3,778 455 10,735
Cardiovascular 15,935 2,600 4,036 394 22,965
Digestive 13,657 5,788 9,411 2,514 31,370
Personal care 2,365 1,481 1,795 206 5,847
Weight management 3,495 925 973 143 5,536
Total net sales by segment $ 64,725 $ 22,107 $ 36,224 $ 5,283 $ 128,339

Nine Months Ended September 30, 2026 Asia Europe North America Latin America and Other Total
General health $ 61,322 $ 31,040 $ 48,484 $ 5,020 $ 145,866
Immune 10,513 6,207 10,299 1,375 28,394
Cardiovascular 38,674 8,845 11,288 1,261 60,068
Digestive 29,179 19,199 30,497 7,980 86,855
Personal care 12,876 3,789 5,615 649 22,929
Weight management 7,672 2,085 2,100 511 12,368
Total net sales by segment $ 160,236 $ 71,165 $ 108,283 $ 16,796 $ 356,480

Nine Months Ended September 30, 2025 Asia Europe North America Latin America and Other Total
General health $ 63,470 $ 29,370 $ 47,535 $ 4,811 $ 145,186
Immune 11,311 6,474 11,887 1,424 31,096
Cardiovascular 42,468 7,804 11,449 1,217 62,938
Digestive 33,825 17,790 27,596 7,599 86,810
Personal care 5,671 4,427 4,907 695 15,700
Weight management 9,297 2,097 2,845 368 14,607
Total net sales by segment $ 166,042 $ 67,962 $ 106,219 $ 16,114 $ 356,337
Schedule of Property, Plant and Equipment by Geographical Area
From an individual country perspective, only the United States has material balances of consolidated property, plant and equipment as follows (dollar amounts in thousands):
September 30,
2026		 December 31,
2025
Property, plant and equipment
United States $ 24,597  $ 29,061 
Other 5,104  3,854 
Total property, plant and equipment $ 29,701  $ 32,915